Bausch Health Companies (TSE:BHC – Get Free Report) released its earnings results on Wednesday. The company reported C$2.52 EPS for the quarter, FiscalAI reports. The company had revenue of C$4.19 billion for the quarter. Bausch Health Companies had a positive return on equity of 87.57% and a negative net margin of 12.02%.
Bausch Health Companies Stock Performance
TSE BHC traded up C$0.80 during trading hours on Wednesday, reaching C$9.67. The company’s stock had a trading volume of 1,065,868 shares, compared to its average volume of 538,670. The company has a current ratio of 1.44, a quick ratio of 0.58 and a debt-to-equity ratio of -1,173.29. The business has a 50-day simple moving average of C$8.65 and a 200 day simple moving average of C$7.94. Bausch Health Companies has a 52 week low of C$6.10 and a 52 week high of C$11.08. The stock has a market cap of C$3.62 billion, a PE ratio of -3.29, a PEG ratio of 0.21 and a beta of 0.82.
Wall Street Analyst Weigh In
Separately, Jefferies Financial Group upgraded Bausch Health Companies to a “hold” rating in a report on Wednesday, July 22nd. Three analysts have rated the stock with a Hold rating. According to data from MarketBeat, Bausch Health Companies has a consensus rating of “Hold”.
About Bausch Health Companies
Bausch Health Companies Inc (NYSE:BHC)(TSX:BHC) is a global diversified pharmaceutical company enriching lives through our relentless drive to deliver better health care outcomes. We develop, manufacture and market a range of products primarily in gastroenterology, hepatology, neuroscience, dermatology, dentistry, aesthetics, international pharmaceuticals and eye health, through our controlling interest in Bausch + Lomb. Our ambition is to be a globally integrated healthcare company, trusted and valued by patients, HCPs, employees and investors.
Further Reading
- Five stocks we like better than Bausch Health Companies
- Boeing Got Its MAX 10 Approval, But Q3 Delivered a Reality Check
- The Invisible AI Backbone: Corning’s AI Fiber Play
- Heavy Metal: Why Nucor Could Be an Overlooked AI Infrastructure Winner
- Why Tesla’s Upside Is About More Than a SpaceX Merger
Receive News & Ratings for Bausch Health Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bausch Health Companies and related companies with MarketBeat.com's FREE daily email newsletter.
